Jadeite Pharma Exp

Sotorasib is used to treat metastatic (cancer that has already spread) or locally advanced (cannot be removed by surgery) non-small cell lung cancer (NSCLC) in patients who have received at least one previous treatment and whose tumors have an abnormal KRAS G12C gene.

Tamoxol 20 Tablet is an anti-estrogens. It is used in the treatment of breast cancer. It is also used to reduce the risk of breast cancer in pre- and postmenopausal women with a high risk. This medicine helps to slow down the growth and multiplication of cancer cells.

Xmalon 25 mg Tablet contains exemestane, an aromatase inhibitor used in the treatment of estrogen receptor-positive breast cancer in postmenopausal women.
It works by lowering estrogen levels, which can slow or stop the growth of certain types of breast cancer cells.
The recommended dosage is 25 mg taken orally once daily, preferably after a meal.
Common side effects may include hot flashes, fatigue, joint pain, headache, insomnia, increased sweating, and mood changes.
Regular monitoring of bone mineral density and vitamin D levels is advised, as exemestane may affect bone health.

Osimertinib is used to help prevent a certain type of non small-cell lung cancer (NSCLC) from returning after the tumor(s) has been removed by surgery in adults.

Capegard 500 mg contains capecitabine, an oral chemotherapy medicine used in the treatment of breast, colon, and stomach cancers. It works by converting into an active form inside the body that interferes with the growth of cancer cells. The tablet is usually taken twice daily with food in treatment cycles as directed by an oncologist. Common side effects include nausea, fatigue, diarrhea, and hand-foot syndrome. Regular monitoring of blood counts and organ function is essential during treatment.

Crizocent 250 mg is used for the treatment of cases who have locally advanced or metastatic non-small cell lung cancer (NSCLC).

Imatinib 100 mg is a targeted cancer medication used to treat conditions like chronic myeloid leukemia and gastrointestinal stromal tumors. It works by blocking proteins that promote cancer cell growth. The tablets are taken orally, usually once daily with food. Common side effects include nausea, fatigue, and swelling. Regular medical monitoring is important to ensure safety and effectiveness during treatment.

Iressa contains gefitinib 250 mg, used for the treatment of non-small cell lung cancer (NSCLC) in patients with specific EGFR gene mutations. It works by blocking signals that promote the growth of cancer cells, helping to slow or stop tumor progression. The tablet is taken once daily, preferably on an empty stomach. Common side effects include diarrhea, skin rash, nausea, and weakness. Treatment should be guided by an oncologist with regular monitoring for effectiveness and side effects.

Gefitinib 250 mg is an oral targeted therapy used to treat non-small cell lung cancer (NSCLC) in patients with confirmed EGFR mutations. It works by inhibiting the epidermal growth factor receptor (EGFR), blocking the signals that help cancer cells grow and multiply. Taken once daily, it offers a convenient option for long-term treatment. Common side effects may include diarrhea, skin rash, and loss of appetite. The medicine should be taken under strict medical supervision with regular follow-ups to monitor response and manage side effects.